Skip to main content
VCbacked
Log inGet Started

Nuvig Therapeutics

Redwood City, United States

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

$161.0M raised
Dec 2024
Series B
BiotechnologyHealth CareTherapeutics

Top Investors

Norwest Venture PartnersB CapitalNovo HoldingsMission BioCapitalBristol-Myers Squibb

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nuvig Therapeutics

How much funding has Nuvig Therapeutics raised?
Nuvig Therapeutics has raised $161.0M in total funding. The most recent round was Series B. The last funding was announced in December 2024.
Who are Nuvig Therapeutics's investors?
Nuvig Therapeutics's investors include Norwest Venture Partners, B Capital, Novo Holdings, Mission BioCapital, Bristol-Myers Squibb.
Where is Nuvig Therapeutics headquartered?
Nuvig Therapeutics is headquartered in Redwood City, United States.
What does Nuvig Therapeutics do?
Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.
What stage is Nuvig Therapeutics at?
Nuvig Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Nuvig Therapeutics — Funding & Investors." VCBacked, December 5, 2024, https://www.vcbacked.co/company/nuvig-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Nuvig Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/nuvig-therapeutics
Wikipedia (cite web)
{{cite web |title=Nuvig Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nuvig-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong